home / stock / drug / drug news


DRUG News and Press, Bright Minds Biosciences Inc. From 12/06/23

Stock Information

Company Name: Bright Minds Biosciences Inc.
Stock Symbol: DRUG
Market: NASDAQ
Website: brightmindsbio.com

Menu

DRUG DRUG Quote DRUG Short DRUG News DRUG Articles DRUG Message Board
Get DRUG Alerts

News, Short Squeeze, Breakout and More Instantly...

DRUG - Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management

Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITE...

DRUG - EH, RX and VFS are among pre market gainers

2023-11-22 08:39:27 ET SciSparc  ( SPRC ) +24% set to merge with a vehicle importer firm in Israel. Bright Minds Biosciences ( DRUG ) +19% . Grom Social Enterprises ( GROM ) +10% signs $8M convertible notes financing agreement. Connect Biopharm...

DRUG - Psychedelic drugs market to break $7B in 2029 led by these 3 meds

2023-09-29 10:00:00 ET More on psychedelic drugs Atai Life Sciences: RL-007, Targeting Schizophrenia Subpopulation With No FDA Approved Therapies With ecstasy a potential PTSD therapy, psychedelic treatments could take off Psychedelic Stocks = Super-Risky Biote...

DRUG - With ecstasy a potential PTSD therapy, psychedelic treatments could take off

2023-09-16 16:00:56 ET On Sept. 14, the Multidisciplinary Association for Psychedelic Studies ("MAPS") announced positive results on a second phase 3 trial for MDMA -- also known as ecstasy -- for post-traumatic stress disorder that were published in a scientific journal. The data in th...

DRUG - Psilocybin in depression: study shows lasting benefit

2023-08-31 12:35:49 ET More on psychedelic drugmakers Compass Pathways: Debt Deal Secured, Cash Runway Extended COMPASS Pathways plc ( CMPS ) Q2 2023 Earnings Call Transcript Mind Medicine Inc. ( MNMD ) Q2 2023 Earnings Call Transcript Psychedelic Sto...

DRUG - Psychedelic therapy should be done in conjunction with psychotherapy - group

2023-08-22 12:50:11 ET More on psychedelic drug companies Psychedelic Stocks = Super-Risky Biotechs Low On Cash. Make Small Bets. COMPASS: The Landscape Is Changing Quickly; Risk Is Up And Potential Down Psychedelic Stocks: Don't Bet On Just 1 Company Seelos:...

DRUG - Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year's End

2023-08-09 08:45:56 ET Palm Beach, FL – August 9, 2023 – FinancialNewsMedia.com News Commentary – About 9.4% of the world population is aged 65 or above. Older people typically consume more medicines than the people in other age group thereby creating the de...

DRUG - YELL, LEJU and DRUG among pre-market losers

2023-08-09 08:32:37 ET Tigo Energy ( TYGO ) -37% reports record revenues and gross profit for second quarter 2023. Bruush Oral Care ( BRSH ) -29% . Fitell Corporation ( FTEL ) -26% . Veritone ( VERI ) -26% after Q2 earning release . ...

DRUG - Bright Minds stock rallies ahead of conference call to discuss Phase 1 data

2023-08-08 13:46:38 ET Shares of psychiatric drug developer Bright Minds Biosciences ( NASDAQ: DRUG ) rallied as much as 100% Tuesday ahead of a schedule conference call with investors to discuss Phase 1 results for its lead drug candidate BMB-101. Bright Minds shares opened at ...

DRUG - CRDF, INFI and GRRR among mid-day movers

2023-08-08 12:46:20 ET Gainers: Infinity Pharmaceuticals ( INFI ) +56% . Bright Minds Biosciences ( DRUG ) +46% . Tilray Brands ( TLRY ) +31% . Paymentus Holdings (PAY) +33% . Gorilla Technology Group ( GRRR ) +28% . Cardiff Onco...

Previous 10 Next 10